 |
Description of how various internal constituencies
(sales reps, medical liaisons, clinical research associates, etc.)
interact with KOLs |
 |
Typical perks offered to KOLS
 |
Research fees |
 |
Access to company data/resources
|
 |
Other |
|
 |
Trends in the relationship model, including impact
of PhRMA guidelines and use of personnel beyond medical liaisons
to interact with these individuals |
 |
CRM software systems used with KOLs
|
 |
Key metrics utilized to evaluate KOL effectiveness
|
 |
Use of social influencing mapping to guide KOL
tactical planning |
 |
Honoraria levels for KOLs
|